NCT06786676View on ClinicalTrials.gov

A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 26, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Healthy
Interventions
DRUG

AS-S603

Oral administration of AS-S603 tablet

DRUG

Placebo

Oral administration of Placebo tablet

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital Clinical Trial Center, Seoul

Sponsors
All Listed Sponsors
lead

Amyloid Solution Inc

INDUSTRY